CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
5% dextrose +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00995670
NCT00995670N/ACompleted

Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins

US Department of Veterans Affairs·interventional·Posted Oct 15, 2009·Updated Mar 17, 2015

In Brief

A clinical study evaluating 5% dextrose, Vitamin C, and 2 other interventions for Hyperglycemia. Completed, enrolled 59 participants across 1 site.

Detailed Summary

Anesthetic preconditioning (APC, a brief exposure to an anesthetic gas) has become an area of intense research interest because of its ability to protect tissue and organs from injury resulting from a cessation of blood flow and then a re-establishment of flow. The blood vessel lining plays a key role in this injury. This research will examine, in human volunteers, several important modifiers of APC in human blood vessels: high blood sugar, vitamin C, and statin drugs. Thus, the proposed studies will advance the investigators' understanding of mechanisms of this injury in humans and explore important modifiers of APC protection from injury.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 15, 2009
Enrollment StartMar 1, 2010
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 16.7 years ago

Interventions

5% dextrosedrug

Glucose is infused to prevent the anesthetic preconditioning (sevoflurane) protection against subsequent ischemia/reperfusion injury.

Vitamin Cdrug

Vitamin C is intended to restore the impairment of the endothelium caused by the dextrose infusion.

Simvastatindrug

Simvastatin will be ingested to determine the efficacy of a statin to modulate the forearm response to glucose.

Sevofluranedrug

Sevoflurane will be given to attenuate or prevent the I/R injury during glucose.